login
login

Europe Daily Bulletin No. 13019

13 September 2022
Contents Publication in full By article 12 / 21
EU RESPONSE TO COVID-19 / Health
EMA recommends authorisation of new adapted vaccine to strengthen European portfolio

12/09/2022 (Agence Europe)The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) announced on Monday 12 September that it has recommended to the European Commission the authorisation of a bivalent mRNA vaccine developed by Pfizer-BioNTech that targets the SARS-CoV-2 sub-variants of concern BA.4 and BA.5 (Omicron) as well as the original SARS-CoV-2 coronavirus strain (see EUROPE B13012A23). The administration of this ‘Comirnaty’ vaccine is...

Contents

SECTORAL POLICIES
EXTERNAL ACTION
INSTITUTIONAL
ECONOMY - FINANCE - BUSINESS
EU RESPONSE TO COVID-19
NEWS BRIEFS